Study Summary
This trial is looking at using MRI to study how a mass in the lung metabolizes sugar.
- Lung Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: During the infusion period blood samples will be collected every 30 minutes (for 2-3 hours) until the end of tumor sampling for mass spec and NMR analyisis of C-glucose in the blood.
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Surgery
1 of 1
Experimental Treatment
225 Total Participants · 1 Treatment Group
Primary Treatment: Imaging Biomarkers · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any available openings in this research endeavor?
"Affirmative. Data hosted on clinicaltrials.gov shows that this medical study, initiated on March 20th 2013, is currently enrolling participants. 225 patients are needed at a single location." - Anonymous Online Contributor
What is the cap on patient enrollment in this clinical trial?
"Right. According to clinicaltrials.gov, this trial is actively enrolling participants since its initial posting on March 20th 2013 and was most recently updated on April 28th 2022. The investigators need to find 225 patients at one location for the experiment." - Anonymous Online Contributor